Tolcapone and neurotoxicity in Parkinson's disease

Lancet. 1998 Oct 17;352(9136):1313-4. doi: 10.1016/S0140-6736(05)70527-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Benzophenones / adverse effects*
  • Brain / drug effects*
  • Brain / metabolism
  • Humans
  • Nitrophenols
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / metabolism
  • Tolcapone

Substances

  • Antiparkinson Agents
  • Benzophenones
  • Nitrophenols
  • Tolcapone